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ONE FISH, TWO FISH, RED FISH, BLUE FISH: THE ANALYSIS OF THE
SPECTER CELL CYCLE MUTANT IN ZEBRAFISH

Tetiana Petrachkova, M.S.
Western Michigan University, 2015

Cell division is controlled by genes that regulate the cell cycle. Here we show that
the zebrafish specter (spr) mutant is mutation in the cyclin B1 gene, a gene necessary
for the G2 to M transition of the cell cycle.
The spr mutation mapped to the cyclin B1 gene. Sequencing showed a transition
(C139T) that caused a nonsense mutation in exon 2 of the cyclin B1 gene. In situ
hybridization of cyclin B1 revealed that the mRNA is absent in the mutant embryo by
gastrulation. We found that the earliest visible mutant phenotype was a darkening of the
head caused by the appearance of apoptotic cells in the brain. In situ hybridization of
markers expressed in neural precursors and blood cells showed that, in general, mutant
embryos have bigger and fewer cells. In situ hybridization of notch1b and deltaa also
showed fewer neural stem cells that give rise to fewer but bigger neuronal precursors.
Phospho-histone-3 antibody staining suggested that the cell cycle is delayed in
the mutant embryo. The expression of the Dual FUCCI transgene in the live spr mutant
embryos confirmed that cells are delayed in the S/G2/early M phase of the cell cycle.
CRISPR/Cas9 mediated germline mutagenesis of the wild-type cyclin B1 allele
showed that the spr mutant phenotype is a result of a nonfunctional Cyclin B1 gene. We
conclude that the spr mutant phenotype is caused by the mutation in the cell cycle gene
cyclin B1, an essential regulator of the cell cycle progression from the G2 to M phase of
the cell cycle. This then leads to mitotic abnormalities and finally developmental arrest.
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CHAPTER I
INTRODUCTION
Background

Genes involved in pathways that regulate the cell cycle in eukaryotes are
being actively studied. Genetic screens in yeast and Drosophila have made
important contributions to understanding pathways regulating cell proliferation. It
has been found that the expression of the human orthologues of the cell cycle
genes identified in model organisms is disrupted in human tumors. The zebrafish
model allows us to study cell cycle gene regulation to understand the cell cycle
progression: its role in early development and cancerogenesis (Krause et al.,
2000; Weaver et al., 2005).
We examined a cell cycle mutation to answer questions as to how some
cell cycle genes are important for the growth and development of the cell and the
whole organism. We now assume that the spr mutation in zebrafish is a mutation
in the cell cycle gene cyclin B1. The product of the cyclin B1 gene is essential for
the control of the cell cycle at the G2 to M transition. There have been studies
done on the role of Cyclin B in oocyte maturation, particularly in Xenopus, but
these studies did not continue to see the role of this protein in tissue
development (Gong & Ferrel, 2010; Frederick and Andrews, 1994). In mice the
knock-out of Cyclin B1, causes homozygous embryos to die in utero (Brandeis et
al., 1998). Since there has not been any study done on Cyclin B1 null protein in
zebrafish, there are several significant questions that we ask in this proposal:
1) is the spr phenotype caused by a mutation in cyclin B1 gene and 2) what are
1

the characteristics of the spr phenotype that affect the cell cycle and
development in zebrafish. Knowing different aspects of how Cyclin B1 is
essential for cell cycle progression will be another link in understanding how cell
division is regulated.

Cell-Cycle Progression During the Maternal-Zygotic Transition

Cell cycle is comprised of the interphase and the actual cell division.
Interphase consist of two Gap phases, G1 and G2, and a Synthesis phase, Sphase. In early development of many organisms, the cell cycle is very short and
synchronous. This period in development is called the cleavage stage and is
characterized by the absence of the G1 and G2 cell cycle stages (Edgar &
Schubiger, 1986). The cleavage stage lasts until the midblastula transition
(MBT). In zebrafish, the duration of mitosis and interphase is the same during
cleavage stage. The MBT begins during cell cycle 10 (512-cell stage), which is
marked by a slowing of the cell cycle. During this period the embryo begins the
transition from maternal to zygotic control of development (Tadros et al., 2009).
The MBT is accompanied by loss of division synchrony, increased cell cycle
duration, activation of zygotic transcription, and an onset of cellular motility (Kane
and Kimmel, 1993). The loss of synchrony is similar to that at cycle 12 in
Xenopus (Newport and Kirschner, 1982) and at cycle 10 in Drosophila (Edgar
and Schubiger, 1986). During the MBT the cell cycle length increases and, as in
Xenopus and Drosophila, this change correlates with the nucleocytoplasmatic
ratio: this ratio increases exponentially as a function of the cycle number, since
2

the total volume of the cytoplasm remains constant while genomic DNA
replicates during each cell cycle (Kane and Kimmel, 1993). After inhibiting
transcription by α-amanitin injection into Xenopus embryos Newport and
Kirschner (1982) suggested that the lengthening of the cell cycle is independent
of transcriptional activation. In Drosophila, the elongation of the cell cycle is
required for transcription complexes to be established. The transcription comes
after cell cycle lengthening, therefore it is independent of transcription (Edgar and
Schubiger, 1986).
With the onset of the MBT, the G2 phase first appears in Drosophila cell
cycle 14, whereas G1 phase appears in cell cycle 16 in the precursors for the
neural and imaginal discs (Edgar and O’Farrell, 1990). The G1 phase in Xenopus
is detected 1 hour after MBT, while the G2 phase appears much later, at the
gastrula stage (Fredrick and Andrews, 1994). Zamir et al. (1997) have
demonstrated by flow cytometry that in zebrafish the G1 phase of the cell cycle is
initially detected at the MBT. Kane and Kimmel (1993) suggested that the
elongation of the cell cycle in zebrafish, caused by the increase of the interphase
duration, particularly the lengthening of the S phase. However, Nogare et al.
(2009) have shown, that it is not G1, but G2 phase that is added during the MBT,
and G2 contributes to the cell cycle lengthening in the deep cells. After cell cycle
10, novel zygotic transcripts might inhibit the immediate entry into S phase, and
thereby induce appearance of G1 phase. One class of such transcripts might be
cyclin-dependent kinase (Cdk) inhibitors. Induced transcription of Cdk inhibitors
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might contribute to the S phase restriction, allowing the appearance of G1 phase
after MBT (Krämer et al., 2004; Sherr and Roberts, 1995).
During cycles 11 and 12, the blastoderm separates into the yolk syncytial
layer (YSL), the enveloping layer (EVL), and the deep cells of the blastoderm.
Yolk cells are characterized by a short cell cycle, the EVL cells have long cell
cycle, and the deep cells have a cell cycle of intermediate length (Kane et al.,
1992). Zamir et al. (1997) suggest that the cell layers located away from the yolk,
where the maternally derived transcriptional repressors are located, may contain
less putative repressors. That maybe why G1 phase appears earlier in the cells
located further from the repressors, e.g. EVL cells (Zamir et al., 1997).
G2 phase appears in cycles 11-13, to ensure the completion of DNA
replication in S phase and prevent premature entry into mitosis. Norage et al.
(2009) determined that a G2 phase is introduced shortly after the MBT in
zebrafish. The major reason for the G2 phase addition, similar to Xenopus and
Drosophila, is establishment of another checkpoint (Pietenpol and Vallier, 2013).
The limitation of maternally provided cyclin mRNA is the reason for the cell cycle
lengthening during blastoderm cellularization in Drosophila. Destruction of
maternally derived Cdc25 (Cell division cycle 25) phosphatase homologs string
and twine mRNAs, (Alphey et al., 1992; Courtot et al., 1992), and activation of
mitotic kinase inhibitor Wee1, which inhibits Cdk1 (Cell division kinase 1),
(Stumpff et al., 2004) results in hyperphosphorylation of Cdk1 and introduction of
a G2/M arrest. Similarly, destruction of maternal Cdc25a occurs in Xenopus
during MBT (Shimuta et al., 2002; Nogare et al., 2009) have shown that the
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inhibition of Cdc25a and Cdk1 acitvity is essential for cell cycle lengthening and
asynchrony cycle 9 through 12. This process begins with the onset of a G2
phase by a transcription-independent mechanism, and contributes to the cell
cycle lengthening in deep cells (Concha and Adams, 1998; Nogare et al., 2009).
Many cells leave the cell cycle due to the onset of differentiation during
division 15, with the rise of notochord cells and a few somatic muscle cells.
Division 16 produces the large primary motoneurons of the spinal cord and more
somatic muscle cells (Lewis and Eisen, 2003). Cell cycle mutants that arrest
early in development, such as zombie, speed bump, and ogre, first show their
phenotypes in these stages (Kane et al., 1996), suggesting that maternal mRNA
might be depleted and there is a lack of zygotic mRNA necessary for normal
development after MBT (Mathavan et al., 2005).

The Role of Cyclin B1 in Cell Cycle Progression

The cyclin family of proteins is known to activate specific Cyclindependent kinases (Cdk) required for progression through the cell cycle (Pines,
1995; Santamaria et al., 2007) (Fig. 1). The Cyclin B1/Cdk1 complex is also
involved in mitotic chromosome condensation (Kimura et al., 1998) and control of
microtubule dynamics during mitosis (Vasquez et al., 1999).
The entry of eukaryotic cells into mitosis is regulated by the activation of
Cdk1 at the G2 to M transition. This transition requires Cyclin B1 to bind with
Cdk1 to form a protein kinase holoenzyme complex, also known as the
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maturation promoting complex (Maller et al., 1989) or mitosis-promoting factor
(MPF) (Draetta et al., 1989; Katsu et al., 1993). Normally, Cyclin B1/Cdk1
remains inactive until enough Cyclin B1 accumulates during S/G2 phase (Allan &
Clarke, 2007). Phosphorylation of Cdk1 at Thr161 by Cdk-activating kinase
(CAK) and dephosphorylation of Cdk1 at Thr14/Tyr15 by Cdc25 proteins are
important steps in activation of the CyclinB1/Cdk1 complex (Timofeev et al.,
2010). The active Cyclin B1/Cdk1 complex must translocate to the nucleus to
begin phosphorylating nuclear substrates, such as caspases to protect mitotic
cells against apoptosis, which is a necessary step for mitosis (Ikegami et al.,
1999; Krause et al., 2000; Porter & Donoqhue, 2003). The Cyclin B1/Cdk1
complex also phosphorylates and disassembles the nuclear lamina in early
prometaphase to promote nuclear envelope breakdown (Li et al., 1997; Nigg,
2001). At the end of mitosis, Cyclin B1 is degraded by the anaphase-promoting
complex (APC/C), promoting the cell cycle progression; cdk1 is constitutively
present (Clijsters et al., 2013; Zachariae and Nasmyth, 1999).

Figure 1. Schematic drawing of the cell cycle.
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A critical target of Cyclin B/Cdk1 activity is the G2 checkpoint (Kastan and
Bartek, 2004; Johnson et al., 2012). There are two possible pathways for a cell at
the G2 checkpoint: cell cycle progression or activation of apoptosis. To prevent
apoptosis, the Cyclin B1/Cdk1 complex phosphorylates caspase-9 at Thr125,
which leads to a block of caspase-9 and caspase-3 activity (Allan & Clarke, 2007;
Plaster et al., 2005), and prevents the cell from undergoing apoptosis. Without
this modification, cells exhibit increased sensitivity to apoptosis. A delay in
mitosis for a prolonged period increases the predisposition of the cells to undergo
apoptosis (Allan & Clarke, 2007). Moreover, arresting human HeLa mitotic cells
using microtubule poisons leads to the inability of the cells to maintain the
CyclinB1/Cdk1 levels needed to block caspases, which leads to activation of
apoptosis after a prolonged mitotic arrest (Allan & Clarke, 2007 Xie et al., 2005).
Therefore, CyclinB1/Cdk1 levels determine one aspect of the fate of the cells
during the cell cycle, to live or to die (Brito and Rieder, 2006). Another study of
Cyclin B1 importance in HeLa cells culture showed that depletion of Cyclin B1
affects its ability to localize at microtubules. Improper attachment of the Cyclin
B1/Cdk1 complex results in lagging chromosomes. However, HeLa cells
depleted of Cyclin B1 can enter anaphase eventually. Omitting chromosome
segregation, cells lacking Cyclin B1 could still enter G1 phase, resulting in
multinuclear cells (Chen et al., 2008; Chen et al., 2013). It is possible that there
are different pathways and players that coordinate the cell cycle progression, and
they remain not fully understood.
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In mammals and zebrafish two types of Cyclins B (B1 and B2) have been
identified (Minshull et al, 1989; Pines & Hunter, 1989). In chicken, frogs, flies and
worms a third type of Cyclin B, called B3 also exists, essential for germline
development (Gallant and Nigg, 1994; Kreutzer et al., 1995).
Mammalian B-type cyclins differ in their NH2 termini and exhibit 57% of the
rest of the protein (Chapman and Wolgemuth 1993; Jackman et al. 2003). Mice
lacking Cyclin B1 die in utero, whereas mice lacking Cyclin B2 are smaller than
normal and have reduced litter sizes. This indicates that Cyclin B1 is essential for
viability, but Cyclin B2 is not (Brandeis et al., 1998). Both B cyclins are detectable
in G1, rise through S phase peaking in late G2 or early M phase, and degrade
after metaphase (Huang et al., 2013). However, differences exist in their cellular
location. Cyclin B1 is primarily cytoplasmic, but constantly shuttles between the
nucleus and the cytoplasm in interphase, whereas Cyclin B2 is primarily bound to
the Golgi apparatus during both interphase and mitosis (Jackman et al., 2003)
and may play a role in segregation of the Golgi apparatus. Recently, however, it
was demonstrated that Cyclin B2 also enters the nucleus during mitosis in HeLa
cells (Huang et al., 2013).
There are four types of cyclins required for proper cell cycle transition. Dtype cyclins (Cyclins D1, D2, and D3) and they are associated with the kinases
Cdk4 and Cdk6 (Duffy et al., 2005). The Cyclin D1/Cdk4 complex phosphorylates
and inhibits members of the rtinoblastoma (Rb) protein family and regulates the
cell cycle during the G1 to S phase transition. E-type cyclins (Cyclin E1 and E2)
associate with Cdk2 and are also required for the G1 to S phase transition.
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Cyclin D expression is mostly dependent on extracellular signals and signaling
cascades, while Cyclin E is regulated by transcriptional activity (reviewed by
Coqueret, 2002). Cyclin A is required to promote DNA replication (Gong et al.,
2010; Nieduszynski et al., 2002).
In Drosophila double mutant embryos that lack both zygotic Cyclin A and
Cyclin B, cell cycle progression has been blocked just before maternally supplied
Cyclins A and B are depleted. The cell cycle is blocked in the G2 phase prior to
entry into the cell division 15 in these mutants. Using heat-shock expression of
Cyclin A or Cyclin B is sufficient for the arrested cells to overcome the block. The
Cyclin B mutants have abnormal spindles and delayed progression through
mitosis. Heat-shock induction of Cyclin B expression completely rescues spindle
abnormalities and the mitotic delay (Knoblich and Lehner, 1993).
Cyclin B1 consists of the destruction box (DB), cytoplasmic retention
signal domain (CRS), N-terminal helix, cyclin box, and C-terminal domain
(Fig. 2).
The first 107 residues of cyclin B1 are necessary and sufficient for
chromatin localization, providing a mechanism to concentrate CDK1 near
chromatin-associated substrates (Bentley et al., 2007). Domain mapping studies
suggest that the N-terminal helix is required for proper protein localization.
Disrupted N-terminal helix of Cyclin B is still able to promote normal Golgi
disassembly, but cannot induce chromosome condensation, nuclear lamina
solubilization and mitotic aster assembly (Draviam et al., 2001). The N-terminal
helix is required for chromatin localization, and localization to kinetochores,
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centrosomes and microtubules within residues 166-433 (Bentley et al., 2007;
Draviam et al., 2001).

Figure 2. Cyclin B1 significant sequence domains.
The destruction box (DB), cytoplasmic retention signal domain (CRS), Nterminal helix (NTH), and cyclin box. Asterisks indicate MRAIL motif (Bentley
et al., 2007).
Bentley et al. (2007) have defined the potential importance of Cyclin B
localization sequences that mediate protein’s localization to specific structures
during mitosis. The DB is required for Cyclin B1 degradation by the APC/C during
the metaphase to anaphase transition. Cyclin B1 with disrupted DB is localized in
the cytoplasm during interphase and localized on chromatin, centrosomes,
spindle microtubules, and kinetochores during mitosis; it delocalizes from
kinetochores during metaphase. This indicates that localization of Cyclin B1 with
disrupted DB is not changed; but APC/C complex cannot degrade Cyclin B1 with
mutation in destruction box domain.
The CRS domain appears to be responsible for the cytoplasmic
localization of Cyclin B and is sufficient to bind and activate Cdk1 (Nugent et al.,
1991). Disruption of the CRS domain results in CyclinB/Cdk1 dissociation,
however no changes in the localization of Cyclin B1 to centrosomes, nor the
10

dissociation of Cyclin B1 from kinetochores after microtubule attachment, or
degradation of Cyclin B1 during the metaphase to anaphase transition occur
(Bentley et al., 2007).
The MRAIL (Met-Arg-Ala-Ile-Leu) motif is required for the substrate
proteins, that contain a hydrophobic Cy motif, binding and located at the opposite
surface of the Cyclin B/Cdk1 catalytic site. Mutants for this motif (P-box mutants)
are able to bind, but not activate Cdc25 (Bentley et al., 2007).

The Specter Mutant

In 1996 the Christine Nüsslein-Volhard group published the Tübingen
mutant screen for mutants that affect embryonic development in zebrafish. The
effect of zygotic genes that are necessary for embryonic survival during the first
day of development still remains unclear. Mutagenesis was performed as
described in Haffter et al. (1996): male zebrafish were mutagenized with ethyl
nitrosourea and outcrossed. Embryos in F3 were screened for mutant
phenotypes that affect morphology in the first 5 days of development.
The spr mutant (alleles ta214 and tu21) was isolated in the Tübingen
screen and identified as mutants that display gross cellular abnormalities in the
first 24 hours of development (Kane et al., 1996). The spr mutant phenotype
becomes visible by the 7-somite stage (12 ½ hours, middle segmentation): an
observed difference occurs in head-to-tail ratio, and the body is underdeveloped
body – it corresponds to the phenotype of a normal 5-somite stage embryo. Initial
studies showed that the spr mutant arrests with a body shape at roughly
11

midsegmentation (24-30 hrs) and eventually exhibits signs of massive
degradation of the nervous system (Kane et al., 1996) (Fig. 3). DAPI staining of
mutant embryos did not show a significant change in nuclear phenotype, but
transplantation studies revealed that >90% cells transplanted from a mutant
embryo into a wild type embryo did not survive if they were transplanted into the
nervous system (Kane et al., 1996).
Mapping of the spr mutation linked it to chromosome 5 (D.A. Kane,
unpublished). Many gene candidates are available within the region, one of
which was the neurotrophic tyrosine kinase receptor (ntrk2b) (Laura Bakke,
unpublished). Trk receptors is a family of tyrosine kinases that regulates synaptic
strength and plasticity in the nervous system. Trk receptors affect neuronal
survival, differentiation, synaptic plasticity, cell morphology and calcium influx
through signal cascades. TrkB binds to the brain-derived neurotrophic factor
(BDNF), important for survival and function of neurons in the central nervous
system. Null trkB mice exhibit similar phenotype to spr: in that
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Figure 3. Morphological characterization of the specter mutant phenotype.
Morphology of (A-G) wild type embryos, (B-H) spr mutant embryos at the 9, 15,
20, and 25-somite stage. Side view.
many trigeminal neurons die during the early stages (Piñon et al., 1996).
However, after Rachel Warga (personal communication) saw that the spr
mutant embryos have enlarged neurons and blood cells, which is a common
characteristic of the cell cycle mutants in our laboratory, the candidate gene was
revised. Further fine mapping revealed the nearby candidate gene cyclin B1 (L.
Bakke, unpublished), a gene that regulates the G2 to M transition in the cell
cycle. Sequencing of mutant cDNA revealed a nonsense mutation (C139T) in
exon 2 (R.M.Warga, unpublished), that presumably results in a non-functional
gene (Fig. 4).
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WT

spr

Figure 4. DNA sequencing chromatogram of the cyclin B1 gene in the specter
mutant embryo.
Sequencing of the cyclin B1 gene reveals a nonsense mutation (C139T) in the
mutant embryo in exon 2 (Rachel Warga, unpublished).
Amber Bard demonstrated by in situ hybridization that the expression of
cyclin B1 is absent by 10-somite stage, which supports our hypothesis that the
spr mutation can be linked to a null Cyclin B1 protein (Fig. 5). Further studies
revealed that the expression of the phosphorylated form of histone H3, which is
the marker for cells undergoing mitosis, was downregulated in the spr mutant
embryos compared to the wild type (J. Singh, unpublished). This study also
revealed that “putative” neural stem cells in the mutant embryo did not divide at
the midline as they do in the wild-type control.
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Figure 5. The specter mutant embryo lacks Cyclin B1 mRNA expression.
In situ hybridization for the Cyclin B1 mRNA in a wild-type embryo (A-E) and
the spr mutant embryo (A’, D’, E’) (Amber Bard, unpublished).
Jyotika Singh also showed by in situ hybridization that the expression of
deltaa, a marker for neural precursors that are still dividing (Appel & Eisen,
1998), was weaker and that these cells were larger in spr mutant embryos
compared to wild-type embryos.

Summary

By characterizing spr mutant embryos we can elucidate the role of Cyclin B in
the cell cycle and early development in zebrafish. In this work I describe the spr
mutant phenotype as the effect of a nonsense mutation in the cyclin B1 gene.
Using in situ hybridization and immunostaining to analyze markers of
specification and differentiation, I show that the spr mutation is indeed a cell
cycle mutation. By mutagenizing embryos in cyclin B1 gene, I show that the spr
mutant phenotype is caused by lack of functional Cyclin B1 protein.
15

CHAPTER II
CHARACTERIZATION OF THE SPECTER MUTANT PHENOTYPE

As described in Chapter I, some characterization of the spr mutant
phenotype had been done, but it was not clear precisely when the morphological
and cellular phenotypes in mutants first appeared and what was the pattern of
those changes. In this chapter I focus on a detailed description of the
morphological and cellular changes during early development of mutants. First, I
will point out alterations in the vascular system, alterations in the precursors of
nervous tissue and alterations in the precursors of the muscular systems.
Second, I will focus on chances at the cellular level, in order to reveal any cell
cycle alterations in mutant embryos. Finally, I will describe cell death pattern
during early development in mutant embryos.

Results
Characterization of the Morphological specter Mutant Phenotype

Experiments in this section were conducted on the embryos derived from
zebrafish heterozygous for spr, therefore on average 25% of embryos were
homozygous for the lethal recessive allele and have the spr mutant phenotype.
Wild-type and mutant embryos were sorted and staged during the first few hours
after fertilization in order to synchronize their development. Later, they were fixed
at designated stages of development.
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The spr mutant morphological phenotype is first distinguishable at the 6somites stage. At this stage the main differences between wild-type and mutant
siblings are smaller head and tail in mutant embryos, and clear boundaries only
in the central somites of the mutants had clear boundaries. At the 10-somite
stage, mutant embryos showed shorter body axes, an opaque head and central
nervous system. Darkening of the head continues to spread along the body axes.
By 24 hours zebrafish wild-type embryos showed motility; in mutant embryos, the
motility pattern is altered and described as an uncontrolled “twitching” of the tail,
which happens more often than the movement in the wild-type embryos.
To describe morphological changes more accurately we examined the
mRNA in different tissues. Cells in vascular and nervous tissues undergo many
rounds of stem cell divisions, producing many cells that commit to different cell
fates within those tissues (Kimmel and Warga, 1986, Kimmel et al., 1994; blood:
Warga et al., 2009). Using in situ hybridization, I determined the pattern of
erythrocytes (hhbe) (Brownlie et al., 1998), macrophages (lplast or lcp1)
(Herbonel et al., 1999) and neutrophils (mpx) (Lieschke 2001; Bennett et al.,
2001) in spr mutant embryos. Erythrocytes and neutrophils are derived from a
common lineage that undergoes frequent rounds of cell division (Warga et al.,
2009). In earlier observation of the mRNA expression of blood markers R. Warga
(unpublished) observed bigger blood cells in mutant embryos. This observation
helped to distinguish the possible functional origin of the defects observed in
mutants: disruption of the cell cycle, because the pattern of bigger and fewer
cells is seen in some zebrafish cell cycle mutants such as zombie and harpy. We
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determined that the mutant embryos had all three types of blood cells (Fig. 6).
And by 24 and 26 hours they were fewer in number and bigger in size.

Figure 6. In situ hybridization of the blood cells markers in the wild-type and the
specter mutant embryo.
In situ hybridization of blood cells markers in wild type (A, C, E) and spr mutant
embryos (B, D, F) at 24 and 26 hours of development. A-B, expression of
hhbe, erythrocytes; C,D, expression of lplast, macrophages; E,F, expression of
mpx, neutrophils. Side view.
In wild-type embryos it is possible to see the blood flow by the second day
of development. Due to the darkness of the mutant body, it is difficult to see the
stream of erythrocytes in spr mutant embryos. I saw the heartbeat in mutant
embryos, but erythrocytes lacked red pigment by the 4th day. In situ hybridization
for blood markers at 24 and 26 hours showed fewer cells. Because this
experiment was so late, one possible explanation for this pattern is a cell death in
the mutant embryos. Another possible explanation for the reduced number of
blood cells is that due to changes in the cell cycle, there could have been fewer
blood cell precursors that could give rise to blood cells.
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pax2a mRNA is expressed in cells in the midbrain-hindbrain boundary,
spinal interneurons, otic placode and kidneys (Krauss et al., 1991). Embryos at
the 10, 15, and 19-somite stage were sorted for the wild-type and the spr mutant
phenotype and fixed. There are transparency changes in mutant embryos,
therefore this marker could confirm if there are any alterations in some parts of
nervous system and some organs. Expression of pax2a mRNA was indeed
decreased in the otic placode and the midbrain-hindbrain boundary (Fig 7).
Spinal interneurons had lower expression of pax2a, they were bigger in size and
were absent posteriorly. Expression in kidneys remained the same compared to
wild-type controls.
islet 1 is expressed in primary motor neurons, branchiomotor neurons,
neurectoderm, hatching gland, epiphysis, nuclei of the telencephalon and the
diencephalon and Rohan-Beard sensory cells (Korzh et al., 1993). Embryos at
16.50, 19 and 24 hours were sorted for the wild-type and the spr mutant
phenotype and fixed. Embryos at 12 hours were not sorted for mutant phenotype,
because it was too early to distinguish it morphologically. At the 15-somite stage
(16.50h) we observed changes in the branchio-motor nuclei of the mutant
embryos, as they do not express islet 1 as strongly as the wild-type controls (Fig.
8 C, D).
No changes of islet 1 expression were detected in the pancreas at all
stages in the mutant embryos. Expression in neurectoderm, epiphysis, nuclei of
the telencephalon and the diencephalon was also decreased in the mutant
embryo.
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Figure 7 In situ hybridization of pax2a mRNA in the wild-type and specter
mutant embryos.

(A, C) the wild-type embryo; (B, D) the mutant embryo at the 15 and 19-somite
stage, respectively. Legend: mhb, midbrain-hindbrain border; os, optic stalk;
ov, otic vesicle; pd, pronephric duct; scn, spinal cord interneurons. Side view.
As for Rohan-Beard sensory neurons, at 16.50, 19 and 24 h, wild-type
embryos had them aligned straight, while the mutant embryos had a different
pattern (Fig. 8, C-E). Rohan-Beard sensory neurons in the embryos were missing
in the posterior part of an embryo, looked bigger, compared to the wild-type
embryo and did not align straight along the body. Same was true for the primary
motor neurons: there were not as many in the mutant embryos and they were
also bigger, compared to the wild-type. Our observations indicate that there were
indeed fewer neurons, particularly sensory and motor in the mutant embryos.
Fewer neurons supports our hypothesis that the possible darkening of the
embryo might be caused by cell death in the nervous system. Also, the lack of
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motor neurons could explain the abnormal motility in mutant embryos at later
stages.

Figure 8. In situ hybridization of islet 1 mRNA in the wild-type and specter
mutant embryos.

(A, C, E, G) wild-type embryos; (B, D, F, E) spr mutant embryos at 12, 16.50, 19
and 24 hours of development, respectively. Legend: hg – hatching gland; bmn,
branchio-motor nuclei, ep, epiphysis; pcr, pancreas, pmn, primary motor neurons,
rb, Rohon-Beard sensory neuron, tc, telencephalon. (A, B) dorsal view; (C-E) side
view.
.

At 12 hours most of an observed group (~75%) had a distinct expression

of islet 1 in the hatching gland, and weaker expression was seen in the
remainder of the clutch. Therefore, we assumed that the remainder, about 25%,
should be spr mutant embryos. The hatching gland stops dividing around cell
cycle 14 (Kimmel et al., 1994; Kimmel and Warga, 1996), therefore we
hypothesized that such a faint expression in the hatching gland in spr mutant
embryos could indicate a delay of its development due to changes in the cell
cycle, particularly in possible delay of mitosis (Fig. 8, A, B).
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notch1b is expressed in the undifferentiated dividing neural stem cells
(Bierkamp and Campos-Ortega, 1993). Embryos at 16.50, 19, 24 and 31 hours of
development were sorted for the wild-type and the mutant phenotype, and fixed.
Embryos at 12h hours were fixed without sorting, as the mutant phenotype was
not clear.

Figure 9. In situ hybridization for notch1b mRNA in wild-type embryos and
specter mutant embryos.

(A,C,E,G, I) Expression in wild type embryos; (B, D, F, H, J) expression in spr
mutant embryos at 12, 16.50 and 19 hours of development, respectively. (A-F)
Side view; (G-J) dorsal view.
At 12 hours, notch1b expression is fainter in mutant embryos and not as
complete as in wild-type embryos (Fig. 9, A, B). At 16.50 hours there was no
difference in notch1b expression between the control and the mutant embryos
(Fig. 9, C, D). At 19 hours we observed a decrease in notch1b expression in the
mutant embryos, which is possibly due to cell death (Fig. 9, E, F). The same
pattern was true for 24 and 31 hours (Fig. 9, G-J). Increased expression of
notch1b in mutant embryos at 16.50 and later stages, compared to the weaker
expression at 12 hours, might indicate the delay in notch1b expression.
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deltaa is expressed in the cells differentiating into neurons (Appel and
Eisen, 1998). According to Jyotika Sigh, expression of deltaa was decreasing
over time in older mutant embryos (24-30 h). To characterize the pattern of
deltaa expression, I sorted and fixed embryos at 14, 16.50, and 24 hours (Fig.
10). Expression of deltaa was weaker in the mutant embryos, compared to the
wild-type control at 14h (Fig. 10, A, B). deltaa positive cells were bigger in spr
mutant embryos (Fig. 10, F, enlarged). At 16.50 and 24 hours deltaa expression
became more intense, however not as bright and strong as in the wild-type
embryos (Fig. 10, C-F).
Stem cells must support their own population and give rise to
differentiated neurons. Mutations in cyclin B1 might prevent these stem cells from
being able to renew and support notch-positive cells, or to differentiate through
the Delta pathway. In the mutant embryos we might observe a situation when
notch cells do not enter the Delta pathway and remain in the Notch pathway due
to a delayed cell cycle, or do not exit the Delta pathway to give rise to neurons.
This would allow us to make the proposal that the pattern of missing neurons that
we observed with islet 1 and pax2a expression in mutant embryos is caused by
the lack of stem cells choosing neural pathway of development.
The myoblast is the type of progenitor cell that differentiates to give rise to
muscle cells. According to initial transplants results with the mutant embryos,
most cells surviving would give rise to muscle (Kane et al., 1996). On the other
hand, possible cell death, lack of cells to give rise to the nervous system and the
delay in nervous system development, could also be true for the mesoderm
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formation. MyoD is expressed in the adiaxial muscle precursors and in segmental
boundaries (Weinberg et al., 1996). To characterize possible changes in
mesoderm development in the mutant embryos, embryos were sorted (except 12
hours) and fixed at 12, 16.50 and 24 hours. Embryos at 12 hours were fixed
without prior sorting (Rachel Warga, unpublished).

Figure 10. In situ hybridization for deltaa mRNA in wild-type embryos and
specter mutant embryos.

(A, C, E) Expression in wild-type embryos; (B, D, F) expression in spr mutant
embryos at 14, 16.50 and 24 hours of development, respectively. Side view.
At 12 hours of development, wild-type embryos had expression of MyoD in
the somites; the spr mutant embryos showed a delayed expression of MyoD at
this point (Fig. 11, A, B). Later, at 16.50 hours MyoD expression returns to the
wild-type strength, but it is disorganized and the somite borders are not clear.
This result was also true for 24 hour stage (Fig. 11, C-F).
Delayed expression of MyoD is consistent with the delayed expression of
islet 1 and notch1b. Interestingly, we did not see diminished expression at later
stages, which might indicate that mesoderm is not affected by cell death as is
nervous system, therefore it does not appear opaque.
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Figure 11. In situ hybridization for MyoD mRNA in wild-type embryos and
specter mutant embryos.
(A,C,E) Expression in wild-type embryos; (B, D, F) expression in spr mutant
embryos at 12, 16.50 and 24 hours of development, respectively. Dorsal view.
It has been shown that MyoD upregulates p21 in muscle cells, and
transactivation of p21 regulates the duration of the G2 phase of the cell cycle
through repression of CyclinB/Cdk1. CyclinB/Cdk1 is responsible for MyoD
phosphorylation, and further degradation of MyoD. Furthermore, if MyoD does
not get phosphorylated, then there is a delay in mitosis entry (Tintignac et al.,
2004). Therefore, this could explain why we see morphological defects in the
somites of the spr mutant embryos.

Characterization of the Cellular specter Mutant Phenotype

I started this part of the work, by repeating a subset of Amber Bard’s
(unpublished) experiments. She showed that the cell cycle in the spr mutant
embryos is not normal, and some cells were bigger, compared to the wild type.
Second, the expression of the phosphorylated form of histone H3, which reveals
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cells undergoing mitosis, was downregulated in the mutant embryos compared to
the wild type starting at the 15-somite stage (Amber Bard, unpublished).
Could I detect a similar pattern of downregulated expression of
phosphorylated form of histone H3, which is as early as I can see the spr mutant
phenotype, which is at 7 somites? Embryos were sorted by the wild-type and
mutant phenotype, fixed at the 7, 15, 20 and 25-somite stage and then
processed for whole-mount in situ hybridization for krox20 to determine
rhombomeres three and five as described in Thisse at al. (1993). Subsequently, I
performed whole-mount antibody staining for the phosphorylated form of histone
H3 (Fig. 12).
At the 7-somite stage the mutant embryos had abnormal shape and showed
fainter staining mitotic nuclei, compared to the wild type (Fig. 12 A, E). Later in
development, wild-type embryos have a distinct alignment of mitotic cells at the
midline. At the 15-somite stage and later, the mutant embryos showed the similar
cellular phenotype as the mutants at the 7-somite stage (Fig.12, F-H). Also,
“putative” neural cells in the mutant embryo did not divide at the midline starting
at the 15-somite stage, as seen in the wild-type control (Fig. 12, B-D, F-H). At the
25-somite stage, mitotic nuclei in the mutant embryos were drastically
fragmented, compared to either mutant embryos at earlier stages of development
or wild type controls at the 25-somite stage (Fig. 12, D’-H’).
Absence of the cells dividing at the midline in the mutant embryos is
consistent with previously shown data by Amber Bard (unpublished). Also, the
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abnormal shape of the mitotic nuclei in the mutant embryos might be caused by
the effects on normal mitotic progression.
D’

H’

Figure 12. The comparison of the mitotic phenotype in wild-type and specter
mutant embryos.
Anti-phospho-histone H3 (pH3) staining with expression of krox20 mRNA in
wild-type (A-D) and spr mutant embryos (E-H) 7- through the 25-somite
stage. The arrow in B shows cell dividing at the midline. Red squares in D
and H indicate areas in D’ and H’.
The second part of mitotic cells analysis consisted of counting nuclei
positive for the phosphorylated form of histone H3 within krox20 stripes (Fig. 13).
It was shown that the number of mitotic nuclei in the mutant embryos is the same
as in wild-type embryos at the 7-somite stage. At the 15-somite stage the number
of mitotic nuclei in spr mutant embryos was significantly lower compared to wildtype control at the same stage, and not statistically different from the mutant
embryos at the 7-somite stage. At the 20-somite stage the number of mitotic
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nuclei in the mutant embryos remained statistically lower compared to the wild
type control, but was statistically greater than in mutant embryos at earlier
stages. At the 25-somite stage the number of mitotic nuclei in the mutant
embryos was significantly lower compared to either wild-type embryos at the 25somite stage or mutant embryos at earlier stages.
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Figure 13. Quantitative analysis of the mitotic cells in wild-type embryos and
specter mutant embryos.
The number of mitotic nuclei in wild-type (grey) and spr mutant embryos
(yellow) between krox20 stripes. Error bars represent standard error.
*p>0.05; **p<0.05.
These data suggest that spr mutant embryos have an equal number of
mitotic nuclei in the analyzed hind-brain area as the mitotic nuclei of wild-type
embryos at the 7-somite stage, although nuclei in mutant embryos differ by
shape and intensity of staining. We think that at the 7-somite stage no more cells
enter mitosis and some cells might get arrested in M phase of the cell cycle.
Later in development, the number of mitotic nuclei in the mutant embryos
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remains almost the same until the 25-somite stage, when mutant embryos are
characterized by vast apoptosis.
We hypothesize that nuclei positive for the phosphorylated form of histone
H3 in mutant embryos do not exit mitosis beginning at the 7-somite stage, rather
they are stopped by, presumably, lack of Cyclin B1. Also, we do not see an
increase in mitotic nuclei with time because the predominant number of cells
could be in G2, and therefore delayed in entering mitosis.
To understand cellular changes in the spr mutant embryos I used DAPI
staining to analyze the nuclear phenotype of the mutant embryos at 7, 15 and 25
somites (Fig. 14). At the 7-somite stage there was no difference in nuclear
morphology, as well as mitotic activity between mutant and wild-type embryos
(Fig. 14, A, B). At the 15-somite stage nuclei of the mutant embryos were
heterogeneous and did not have as many dividing cells, compared to the nuclei
of wild-type embryos (Fig. 14, C-D) At the 25-somite stage, mutant cells did not
show such high heterogeneity in size, and they were all at least twice as big as
the wild-type cells at this stage (Fig. 14, C, F).
In the phospho-histone H3 analysis, I saw changes in the shape of the spr
mutant cells beginning at the 7-somite stage, but in the DAPI analysis, no
changes in cellular morphology were detected. In the mitotic analysis for later
stages, I did not see cells in mitosis larger in size, compared to the wild-type
control, unlike in the DAPI assay. The inconsistency in the results from the two
assays might be explained by only a small portion of the cells analyzed in the
pH3 assay and no complete picture is seen of how the cell cycle changes in the
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mutant embryos. On the other hand, in the DAPI staining experiment I was
looking at all the cells in the embryo.

Figure 14. The nuclear phenotype of wild-type and specter mutant embryos.
DAPI staining of nuclei of wild type embryo (A-C) and the spr mutant embryo (DF) at 7-, 15-, and the 25-somite stage, respectively. At the 7-somite stage nuclei
appear to be equal in size, no abnormal nuclei are observed. At the 15- and the
25-somite stage nuclei of the spr mutant embryo are bigger, have abnormal
shape. Bar = 20 µm.
In order to study this question more precisely, I used the Dual FUCCI
(Fluorescnet Ubiquitination-based Cell-Cycle Indicator) technique (Abe et al.,
2012; Bouldin et al., 2014; Sugiyama et al. 2009). Bouldin et al. (2014) recently
created an improved version of the Dual FUCCI system, expressing both probes
of zCdt1 and zGeminin. This construct is comprised of Flag-Cerulean-zGem1100 followed by a viral 2A peptide and mCherry-zCdt1-190 (Fig. 15).
Instead of using the EF1α promoter, limited to early development
(Sugiama et al., 2009), the Dual FUCCI system uses the zebrafish ubiquitin
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promoter, which is expressed ubiqiotously and can be visualized beginning at the
50% epiboly stage, with no further limitation in time (Bouldin et al., 2013).

Figure 15. Schematic representation of the dual FUCCI reporter.
zGeminin degron cloned downstream from a 3xFlag tag. Flag-CeruleanzGeminin placed downstream of a viral 2A peptide. mCherry-zCdt1 fusion
protein was placed downstream from the 2A peptide and inserted in a plasmid
Tol2 elements and the ubiquitin promoter. Adapted from Bouldin et al., 2013.
Construct is comprised of Flag-Cerullean-zGeminin, DNA-replication inhibitor;
followed by a viral 2A peptide; and mCherry-cdt1, DNA replication factor. The 2Aviral peptide allows translation of a multiple protein products. This gives rise to
two flourophores produced as independent proteins from a single transcript. 2A
region encodes a polycystronic sequence that mediates self-processing and
allows a continuous translation. Therefore Dual FUCCI polypeptide gives rise to
Cerulean-based S/G2/M reporter, and a Cherry-based reporter, detectable at the
G1 stage. zGeminin is a DNA replication inhibition, which accumulates in the
nuclei and cytoplasm, it reveals morphology of individual cell that have
undergone DNA replication (Sugiyama et al. 2009). Geminin is absent during G1
phase and accumulates through S/G2/M phases of the cell cycle. At the
metaphase to anaphase transition, APC/C degrades Geminin through
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ubiquitination (McGarry and Kirschner, 1998). Thus, we can visualize cells in
S/G2/early M stage of the cell cycle. Cdt1 (Chromatin licensing and DNA
replication factor 1) – DNA replication factor, with maximum concentration in G1
phase. Thus, we can visualize cells in the G1 stage.
We hypothesized that wild-type embryos should have cells predominantly
in the G1 phase of the cell cycle (Sugiyama et al. 2009; Pauklin & Vallier, 2013;
Kimelman, 2014), and if the spr mutant embryos lack functional Cyclin B1, most
of the cells should be arrested in G2/M phase, according to previous studies
(Allan and Clarke, 2009; Chang et al., 2003; Shepard et al., 2005). Wild-type and
mutant embryos carrying Dual FUCCI transgene were synchronized in
development and sorted by the morphological phenotype at the 20-somite stage
and then visualized by confocal microscopy (Fig.16). We found that cells in wildtype embryos were indeed in the G1 phase of the cell cycle with few cells in
S/G2/M phase. Cells of the spr mutant embryos indeed had much more “blue
cells”, than “red cells”, meaning that most of the cells were in S/G2/M phase.
Considering that there is no nuclear envelope during mitosis, Dual FUCCI system
does not allow us to visualize M-phase of the cell cycle (Pauklin & Vallier, 2013).
Therefore, the blue cells in the spr mutant embryos are the cells in S and G2
phase. Cells in G1 phase have an altered morphology, compared to the wild-type
cells in G1 phase. Cells in S/G2 phase are bigger, than in wild-type, which could
suggest that mutant embryos might undergo some type of endoreplication.
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Figure 16. Cell cycle visualized with the dual FUCCI reporter system in the live
wild-type embryo and the specter mutant embryo.
(A-A”) the wild-type embryos; (B-B”) the spr mutant embryo at the 20-somite
stage. (A-B) cells in G1 stage, Cdt1-mCherry (red); (A’-B’) cells in S/G2/early M
phase, zGem-Cer (blue); (A”-B”) merged image. Bar = 20 µm.
Abnormal looking cells in the spr mutant embryos indicate that many cells
die. Thus, I wanted to follow the changes in apoptosis pattern in mutant embryos.
Apoptosis in the specter Mutant Embryos

Because we observe darkening in the anterior part of the spr mutant
embryos, first we hypothesized that apoptotic cells should first appear in this
area. Darkening of the embryo in the rostral area might be due to the increased
size of the cells. Also, Amber Bard’s data seems to show apoptosis started in the
mutant embryos in the head. According to Cole and Ross (2001), apoptosis
normally occurs in the nervous system of the zebrafish in a rostral to caudal
manner by 12 hours. In their study apoptotic cells localized at the dorsal midline,
33

suggesting that these are neural precursors cells. Because development
proceeds in a rostral to caudal manner and formation of the neural keel, which
gives the rise to the brain and spinal cord, follows this pattern the authors
suggest that apoptosis is a way of diminishing excess cells during development
of the nervous system (Cole & Ross, 2001).
A critical target of Cyclin B/Cdk1 activity is the G2 checkpoint (Kastan &
Bartek, 2004). There are two possible pathways for a cell after it enters G2
checkpoint: cell cycle progression or activation of apoptosis. To prevent
apoptosis, the Cyclin B1/Cdk1 complex is responsible for the phosphorylation of
caspase-9 at Thr125, which leads to a block of caspase-9 and caspase-3 activity
(Allan & Clarke, 2007), and prevents the cell from undergoing apoptosis. Without
this modification cells exhibit increased sensitivity to apoptosis. Delay in mitosis
for a prolonged period increases the predisposition of the cells to undergo
apoptosis (Allan & Clarke, 2007). Moreover, arresting human HeLa mitotic cells
using microtubule poisons leads to inability of the cells to maintain
CyclinB1/Cdk1 levels needed to block caspases, which leads to activation of
apoptosis after a prolonged mitotic arrest (Allan & Clarke, 2007). Therefore,
CyclinB1/Cdk1 levels determine one aspect of the fate of the cells during the cell
cycle, to live or to die. The spr mutant embryos lack functional Cyclin B1, which
possibly interferes with required levels of CyclinB1/Cdk1 resulting in activation of
apoptosis pathways.
To analyze dynamics of apoptosis I first determined when apoptosis
started using an antibody that detects the phosphorylated form of caspase-3,

34

which is normally only phosphorylated once the caspase cascade is initiated in
the apoptotic pathway (Negron & Lockshin, 2004).This revealed that apoptosis
was not detected until the 10-somite stage (Fig.17). These data suggest that
morphological changes in the spr mutant embryo by the 7-somite stage, the
earliest stage the mutant phenotype is visible, are not due to apoptosis. Next, I
counted the number of apoptotic cells within the forebrain and the midbrain area.
To identify this region I used the mRNA expression of pax2a, which is expressed
in the optic stalk (forebrain) and in midbrain-hindbrain boundary. pax2a is also
expressed in the kidneys, otic vesicle and a spinal cord interneurons (Krauss et
al., 1991). Embryos were fixed at the 5, 7, 10, 15, 20 and 22-somite stage and
then processed for whole-mount in situ hybridization as described in Thisse et al.
(1993). Subsequently, I performed whole-mount antibody staining for the
phosphorylated form of caspase-3 (Fig. 17). Finally, I counted the number of cells
expressing the phosphorylated form of caspase-3 between the optic stalk and the
midbrain-hindbrain boundary. In all but the 10-somite stage, I was able to sort the
mutant embryos from the wild types before fixation.
Analysis at later stages (15-, 20- and 22-somite stage with animals of
three clutches for each stage) revealed that all mutant embryos had significantly
more apoptotic cells than the wild type, and that the number of apoptotic cells in
the mutant embryo increased over time from a maximum of 106±13 by the 15somite stage to 177.97±5.77 by the 20-somite stage (Fig. 17, B’, C’; Fig. 18).
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Figure 17. The analysis of an apoptosis in the wild-type control and specter
mutant embryos.

In situ hybridization for pax2a mRNA and antibody staining for the phosphocas-3 (A-C) the wild-type control; (A’-C’) spr mutant embryos at the 10-, 15-,
and 20-somite stage, respectively. Panels to the right: enlarged view of the
head, where apoptotic nuclei were counted. (A”, B”, C”) the number of apoptotic
nuclei at the 10-, 15-, and 20-somite stage in the wild-type control (black frame)
and the mutant embryos (red frame). Legend: ar – anterior retina; os, optic
stalk; mhb, midbrain-hindbrain border; ov, otic vesicle; pd, pronephric duct; scn,
spinal cord interneurons.
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Figure 18. The mean number of apoptotic cells in the wild-type control and
specter mutant embryos.
Grey bars – wild-type; yellow bars – mutant embryos at 15- and 20-somite
stage. Data adapted from Fig. 17, B” and C”. Bars indicate standard deviation.

At the 10-somite stage the number of apoptotic cell varied. There was a
group of animals (approx. 1/3) that had many apoptotic cells (from 50 to 102
apoptotic cells) (Fig. 17, A’). There was a group of animals (approx. over 1/3)
with few apoptotic cells (from 2 to 25 apoptotic cells), inferred as “wild-type”.
However, there was also a group that could be a “dominant effect”, because I
could not determine if these animals represent mutants with fewer apoptotic cells
or wild type with an elevated apoptosis rate (from 33 to 55 apoptotic cells). This
same phenotype was observed in two independent clutches. In the third clutch
the “dominant effect” group was shifted to the right, suggesting that the “wildtype” phenotype corresponds to 2/3 of the clutch.
These results suggest that already by the 15-somite stage there is a high
amount of apoptosis in the forebrain – midbrain area of the spr mutant embryo
(Fig. 18). It also supports our hypothesis that the cells in the mutant embryo
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eventually undergo apoptosis which gradually increases with time of
development. This supports our proposal that opaque embryos can be explained
by exceeding apoptotic cells and degeneration of tissues.

Summary

In this section I characterized the spr mutant phenotype in detail. The
observation of morphological phenotype revealed specific mutant morphological
characteristics beginning the 7-somite stage. Through in situ hybridizations I
have showed that the mutant embryos have fewer and bigger cells in vasculature
and nervous systems, which supports our proposal that the mutant embryos are
cell cycle mutants. The cellular phenotype was characterized with antibody
staining for the mitotic marker, which suggested that cells do not enter the next
cell cycle after the 7-somite stage, possibly due to the lack of Cyclin B1 protein.
By DAPI staining I showed that nuclei in the mutant embryos have abnormal
shape and most of the cells are bigger in size. Also, I showed that the cell cycle
progression in the mutant embryos is not normal, due to a majority of the cells
being in S/G2/ early M stage, while the cells in the wild-type embryos remain in
G1 stage at that time. The cellular phenotype also supports the hypothesis that
the mutant embryos have a disruption in normal cell cycle progression. Loss of
cells and the opaque body of the mutant embryos was explained by an active
apoptosis. In the following chapters I will show that the mutant phenotype is
caused by a mutation in the cyclin B1 gene.
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CHAPTER III
ATTEMPTED RESCUE OF THE SPECTER MUTANT PHENOTYPE

Background
mRNA Rescue

As Don Kane, Laura Bakke and Rachel Warga (unpublished) showed, the spr
locus mapped in the vicinity of the Cyclin B1 locus and the spr mutant embryos
are characterized by a nonsense mutation in exon 2 of cyclin B1 gene. This
mutation results in a premature stop codon in the transcribed RNA, and
nonfunctional Cyclin B1 protein. To reduce errors in gene expression, mRNA
transcripts that contain premature stop codon are eliminated through nonsense
mediated mRNA decay (Chang et al., 2007). We assumed that the lack of
functional Cyclin B1 disturbs the transition from G2 to M phase of the cell cycle.
cyclin B1 mRNA is maternally supplied to the embryo, which remains sufficient
through the first fifteen cell cycles. Considering that mutant embryos do not
express endogenous zygotic cyclin B1, we hypothesized that by providing wildtype cyclin B1 mRNA using microinjections could rescue the spr mutant
phenotype. “Rescuing” the mutant phenotype would demonstrate it is a result of
the mutation in cyclin B1 gene. cyclin B1 mRNA is constantly degraded, therefore
without continuous supply of wild-type cyclin B1 mRNA, mutant embryos are not
provided with enough Cyclin B protein and cannot be fully rescued.
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Injection of in vitro transcribed mRNA is the most common way to test our
hypothesis (Hammerschmidt et al., 1999). Huang et al. (2013) have shown the
transient rescue of the mitotic defect in emi1 mutant embryos through injection of
wild-type mRNA: the rescue effect was evident through gastrulation, it declined
by the tailbud and was absent by the 18-somite stage. This provided the
evidence that their candidate gene had been identified correctly. A purpose of the
experiments in this chapter is to confirm that spr mutant phenotype is a result of
a non-functional Cyclin B1 protein.
I have attempted to “rescue” mutant phenotype by injecting synthetic wildtype cyclin B1 mRNA into embryos from a heterozygous cross at the 1-2-cell
stage. I would not expect full rescue, because the amount of synthetic wild-type
mRNA required to provide enough protein might be toxic to an embryo.

Results
mRNA Rescue of the specter Phenotype
To confirm that the spr mutant phenotype is a result of a mutation in the
cyclin B1 gene, I injected synthesized wild-type cyclin B1 mRNA into embryos
derived from a heterozygous cross. As a control, I injected kaede mRNA,
originally isolated from the stony coral Trachyphylia geoffroy. Kaede is a nontoxic green fluorescent protein that does not interfere with early development of
embryos (Hatta et al., 2006). First, I determined the lethal threshold for the wildtype cyclin B1 mRNA. By performing injections of wild-type cyclin B1 mRNA in
different concentrations (30-70 pg). After a series of such experiments, I
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determined that the concentration of >52pg was damaging and lethal for the
embryos. To distinguish any developmental delay after mRNA injections, I
injected kaede mRNA in the control embryos in the same concentration as cyclin
B1 mRNA. kaede mRNA injected embryos had the same delay in development
as cyclin B1 mRNA injected embryos, compared to uninjected group.
Most injection experiments I used on average 30-50 embryos in each
control and test group, with the remainder of the embryos left uninjected.
Because spr is a recessive Mendelian mutation, 25% of the embryos derived
from a heterozygous cross will have the spr mutant phenotype. After a series of
different mRNA concentration experiments, I was not able to distinguish the spr
mutant phenotype at the 7-somite stage, unlike in control group, when I used
52 pg of cyclin B1 mRNA. This suggested that this was the right concentration to
see a possible rescue phenotype. Not until the 15-somite stage was I able to
determine mutants in the injected group, due to the length of the body axis, which
were shorter possible due to the fewer cells.
To determine any changes in cellular phenotype, I have used DAPI
staining of embryos injected with kaede and cyclin B1 mRNA. No significant
changes were observed within the two injected groups.
I assayed the number of apoptotic calls in the “rescued” mutants using in
situ hybridization and antibody staining methods, to determine the effect a wildtype cyclin B1 mRNA was having on the spr apoptosis phenotype. I preferred
using injected embryos fixed at the 15-somite stage, because at that point it was
easy to determine the phenotype of wild-type and spr mutant embryos, as
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described in Chapter II. In addition, I also had extensive data on the apoptosis
dynamics and the pattern at the 15-somite stage in uninjected embryos (Fig.
17, B-B”). Figure 19 represents the data of two experiments and showing the
number of apoptotic cells in the midbrain-hindbrain area of embryos injected with
kaede and cyclin B1 mRNA.

Figure 19. Number of apoptotic cells in embryos injected with the wild-type
cyclin B1 mRNA.
No rescue effect was detected after the wild-type cyclin B1 mRNA injections.
The number of apoptotic nuclei in embryos injected with kaede (blue) and wildtype cyclin B1 mRNA (orange). Embryos were fixed at the 15-somite stage. A,
injected: 42-46 pg of wild-type cyclin B1 mRNA; total number of embryos
injected with kaede n=33, with wild-type cyclin B1 mRNA n=28. B, injected:
52 pg of wild-type cyclin B1 mRNA; total number of embryos injected with
kaede n=46, with wild-type cyclin B1 mRNA n=43.
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The number of apoptotic cells in the kaede injected control did not differ from
former experiments (Fig. 17, B”). This suggests that kaede mRNA did not
interfere or disrupt the morphological, or cellular phenotype of the embryo. Wildtype cyclin B1 mRNA did not cause a significant decrease of apoptotic cells in
mutant embryos. According to these data, I did not confirm any rescue effect of
spr mutant phenotype from wild-type cyclin B1 injections.

Summary

In this chapter I have shown that endogenous cyclin B1 mRNA injected
into the spr mutant embryos during early cleavage stage does not have any
rescue effect. No partial or full rescue effect was noticed in morphological and
cellular phenotypes, and no difference in apoptotic patterns. No significant
phenotypic effects suggests that this experiment did not prove that Cyclin B1 is
the right candidate for the mutants. However, in this case there might not be
sufficient levels of injected cyclin B1 mRNA, since the dynamic change in protein
levels may require transcription at every cell cycle after cleavage divisions.
Therefore, in the next chapter I will show what effect does the disruption of cyclin
B1 gene has on zebrafish embryos using CRISPR/Cas9 system.
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CHAPTER IV
CRISPR/CAS9 SYSTEM
Background

CRISPR/Cas9 System as an Efficient System of Genome Editing

Clustered regulatory interspaced short palindromic repeats (CRISPR) and
CRISPR-associated proteins (Cas) have recently been established as an efficient
tool for gene disruptions (Auer et al., 2014; Gangnon et al., 2014; Hwang et al.,
2013; Irion et al., 2014; Wiedenheft et al., 2012). Other editing tools, such as
zinc-finger nucleases and transcription activator-like effector nucleases
(TALENs) are also effective genome editing systems, however they are limited
by the cost of methods and a requirement for substantial molecular cloning (Gaj
et al., 2013; Gagnon et al., 2014).
Bacteria and archaea integrate short fragments of foreign nucleic acid into
the host chromosome at one end of the CRISPR locus as an adaptive defense
mechanism againts invading conjugative plasmids, transposable elements, and
viruses (Brouns et al., 2008). Originally, CRISPRs were described in Escherichia
coli as an “unusual sequence element”, consisting of 29-nucleotide repeats
separated by “spacer” sequences. These sequences function similarly to a
genetic memory to defend a host from being infected by viruses containing this
recognition sequence (Brouns et al., 2008).
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There are three types of prokaryotic CRISPR immune adaptive systems.
The type II CRISPR system from Streptococcus pyogenes consists of Cas
endonucleases to target and cleave invading foreign DNA, CRISPR RNA
(crRNA) and a trans-activating RNA (tracrRNA) for sufficient RNA-guided
cleavage of foreign DNA by Cas proteins. Recent studies showed that crRNA
and tracrRNA chimera guide RNA (sgRNA) can direct Cas9 endonucleasemediated cleavage of target DNA (Jinek et al., 2012). Cas9 can introduce sitespecific DNA double-stranded breaks in vitro (Jinek et al., 2012), in mammalian
cell lines (Fu et al., 2013), bacteria (Brouns et al., 2008; Wiedenheft et al., 2012),
yeast (DiCarlo et al., 2013), zebrafish (Auer et al., 2014; Hwang et al., 2013; Irion
et al., 2014; Auer & Bene, 2014; Jao et al., 2013), nematodes (Chen et al., 2013)
and mice (Wang et al., 2013). CRISPR/Cas9 system targets any sequence 5’GG-N18-NGG-3’. The range of available sequences is limited by T7 promoter,
used to make sgRNA (GG at the 5’end of the transcript) and by the protospacer
adjacent motif (PAM) sequence NGG in genomic DNA 3’ to the target site
(Hwang et al., 2013; Wiedenheft et al., 2012).
In this chapter I describe how we used CRISPR/Cas9 system to
mutagenize the cyclin B1 associated locus. This method allows specific gene
disruption, such as small insertions or deletions (indels) introduced during the
repair of cleaved DNA by nonhomologous end joining and homology directed
repair causing frameshifts and premature stop codons (Auer & Bene, 2014). I
hypothesized that by editing the functional cyclin B1 gene using CRISPR/Cas9
system, I could reproduce the spr mutant phenotype. To test this, I conducted
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several experiments: mutagenizing the functional cyclin B1 gene in somatic cells
and germline clones; and a complementation test.
Results
Mutagenizing of the functional cyclin B1 gene

By editing the functional cyclin B1 gene using CRISPR/Cas9 construction
that would recognize 20 nucleotides of the second exon of the cyclin B1 gene on
chromosome 5, a site upstream of the mutation that occurs in the spr mutant
embryos, I tried to reproduce the spr mutant phenotype. sgRNA can direct Cas9
endonuclease activity to alter endogenous genes in zebrafish embryos. Dr. Kane
(unpublished) constructed expression vectors that enable T7 RNA polymerasemediated production of a capped, polyadenylated mRNA, encoding monomeric
Cas9 endonuclease and sgRNA carrying specific 20 nucleotides – a targeting
region complementary to a sequence in the cyclin B1 gene (Fig. 20).

Figure 20. Schematic representation of the CRISPR/Cas9 system, recognizing
the target site within the exon 2 of the cyclin B1 gene.

AG (first two nucleotides of the target site) is a donor site. Grey frame, exon 2
on chromosome 5; blue, guide RNA; green, target site; red, PAM site; yellow,
nonsense mutation site in the spr mutant embryo (C139T). Ellipsis indicate
omitted 84 and 6 nucleotides of the sequence.
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To determine the optimal quantity of RNA for genome editing, we
microinjected varying amounts of cyclin B1-targeted sgRNA and Cas9-encoding
mRNA into 1-2 cell stage zebrafish embryos, derived from the wild-type fish
crossed to heterozygous for spr fish. One half of the embryos from such cross
must carry two wild-type alleles, and second half should be heterozygous and
carry one wild-type allele. By injecting CRISPR/Cas9 mRNA into these embryos
and disrupting one allele, we expected to see a mosaic spr phenotype in 50% of
the embryos that originally were heterozygous for the spr mutation. As control, I
had two additional groups: one injected with only Cas9 mRNA, and second group
was left uninjected. After injection, embryos were left in the incubator (33°C) and
monitored periodically throughout the progression of development.
We found that most of the injected embryos showed severe morphological
defects and early death caused by high apoptosis rates. Therefore, we assumed
that this could be an indication of off-target mutations caused by CRISPR/Cas9
system, as these mRNAs might be toxic for embryos. Optimal quantity of RNA,
which did not cause as severe damage to embryos, was 153 pg. Morphological
characteristics of CRISPR/Cas9 injected embryos did not reveal spr mutant
phenotype, therefore I looked closer at the cellular phenotype.
To check if I was able to mutagenize some clones within CRISPR/Cas9
injected embryos, I performed whole-mount antibody staining for the
phosphorylated form of caspase-3 (Fig. 21). I described this method in Chapter
II, as apoptosis is an essential characteristic of the spr mutant phenotype, and
can help us to determine whether injected embryos developed any apoptosis
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pattern similar to the in the mutant embryos. Apoptosis pattern in embryos
injected with CRISPR/Cas9 and Cas9 was almost the same: embryos had
groups of apoptotic cells in the yolk and around the midbrain area. However,
embryos injected with only Cas9 usually showed apoptosis in the whole embryo,
rather than in some parts of it, than in CRISPR/Cas9 injected group.

Figure 21. Somatic mutagenesis of the specter heterozygote embryo using the
CRISPR/Cas9 system.
Antibody staining for the phosphorylated form of caspase-3 of CRISPR/Cas9
injected embryos at the 18-somite stage.
Since the possible mutant phenotype should be mosaic, I could not
concentrate on apoptotic cells only in one area, as it was described in Chapter II.
I counted the number of apoptotic cells in the whole embryo in the uninjected
control group, Cas9-injected group and CRISP/Cas9 injected group at the 15somite stage. I hypothesized, that if we are able to create a mosaic spr mutant
phenotype using CRISPR/Cas9 system, we would expect higher rates of
apoptosis in 50% of the embryos (heterozygous embryos) in the test group
(injected with CRISPR/Cas9), and lower rates in all embryos in 2 control groups.
Results of the experiment are presented in Fig. 22.
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Unfortunately, I did not see the expected 1:1 ratio in CRISPR/Cas9
injected group, probably because of the Cas9 (1:1) destructive effect. The
apoptosis level was elevated in both CRISPR/Cas9 and Cas9 injected groups,
unlike in the uninjected group. Therefore, we assumed that the Cas9 indeed had
a toxic effect on zebrafish embryos and the resulting phenotype cannot be
considered as an effect of a direct CRISPR/Cas9 mutation in cyclin B1 gene.
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Figure 22. The analysis of apoptosis in embryos mutagenized with the
CRISPR/Cas9 system.

The number of apoptotic nuclei in uninjected embryos (grey), injected with
Cas9 mRNA (orange), and with the CRISPR/Cas9 mRNA (blue). (A) The
number of apoptotic cells in the embryos from a heterozygous cross, where
25% of embryos (framed) reveal the spr mutant phenotype. Red points in (E)
indicate >400 apoptotic cells.
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Phenotype of non-complementation in spr heterozygous embryos injected with
the CRISPR/Cas9 mRNA

In a second experiment, we mutagenized wild-type zebrafish embryos with
no spr mutant background using the same CRISPR/Cas9 mRNAs for injections.
We disrupted a wild-type allele of the cyclin B1 gene, creating a heterozygous
mutant. We grew up putative founders from this cross and crossed them with
known spr heterozygotes. We tested whether the mutagenized allele fails to
complement the original gene, in the progeny of such cross, and is therefore
allelic. Therefore, this method could reveal and confirm whether the spr mutant
phenotype is caused by the lack of functional cyclin B1.
To mutagenize fish, we injected wild-type embryos with CRISPR/Cas9 mRNA at
concentrations from 8.5 to 13.52 pg of CRISPR/Cas9. The total number of
embryos injected with CRISPR/Cas9 mRNA was about 1300. On average, in
every experiment, I injected around 300 embryos at 1-16 cell stage. Embryos
tend to die during the first few days of development (Table 1). The most lethal
were the first two experiments probably because of high mRNA concentrations
injected. According to the data on apoptosis that was conducted with injecting
heterozygous embryos for the mutant spr allele, this might explain high lethality
rates in this experiment as well. For this reason, we lowered the concentration of
injected CRISPR/Cas9 mRNA to 6.76pg. Further experiments had more success,
as measured at the first week after injection. However, many fish were lost, and
after 3 months we were left with five fish.

51

Table 1. Survival Rates of Embryos Injected with CRISPR/Cas9 mRNA at
2-16 Cell Stage.
Concentration of Number of
CRISPR/Cas9
embryos
mRNA injected, injected
pg
8.45
242
13.52
52
6.76
313
5.07-8.45
293
6.76
281
6.76
119
Total number
1300

Number of
injected
embryos, 1
day old
44
22
265
113
176
70
690

Number of
injected
embryos, 1
week old
8
9
105
52
40
36
250

Grown to
adult fish

5

Similar fish losses occurred with normal fish growing at that time, although other
off-target mutations might have disrupted normal development as well, and the
fish have been weaker. During 3 months of development many fish were lost,
due to unknown reasons, and we were left with only 5 fish.
To determine if the founders were carrying spr mutations, we crossed
these 5 fish with spr heterozygotes and looked for mutants via lack of
complementation. Out of 5 fish, only one male crossed to a spr heterozygote
gave progeny that resembled the spr mutant phenotype (Fig. 23, C): shorter body
axes, different head shape, smaller head, opaque anterior axes.
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Figure 23. CRISPR-mediated cyclin B1 mutagenesis.
(A) The morphological phenotype of a wild type embryo, (B) the spr
homozygote and (C) the transheterozygote at the 18-somite stage.
Cellular phenotype of the clones I characterized using Dual FUCCI
reporter system (Fig. 24) that was described in Chapter II (Fig. 10).
Embryos from the same cross were sorted for wild-type and
putative spr mutant phenotype. The Dual FUCCI reporter gene allowed
visualization of the cell cycle in the live embryos at the 20-somite stage. The
majority of the cells in wild-type embryos were in G1 stage, as Cdt1-mCherry
accumulates during G1 stage, with several cells in S/G2/early M phase (zGemCer) (Fig. 24, A-A”). The majority of the cells in spr mutant embryos, as was
shown in Chapter II, reveal that most of the cells were in S/G2/early M phase
(Fig. 24, B-B”). Cells in G1 stage of spr mutant embryos had an irregular,
abnormal shape and showed signs of apoptosis, cells in S/G2/early M phase
were enlarged with no changes in the cell shape, compared to the cells in the
wild type embryos. The majority, but not as many as in spr mutant embryos, of
the cells in embryos derived from the non-complementation test also were in
S/G2/early M phase (Fig. 24, C-C”). All the cells were enlarged, and cells in G1
phase also had an irregular shape.
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A clone of mutant progeny represents a mutation in a germ line cell. By
injecting CRISPR/Cas9 system into embryos during zygote and early cleavage
stage we can mutagenize progenitor germline cells. Having 10% clone size
means that 40% of the cells in the germline contains the mutation.

Figure 24. The cell cycle of the CRISPR-mediated cyclin B1 mutagenized
embryo.
(A-A”) Live wild-type embryo; (B-B”) the spr mutant embryo; (C-C”) the
transheterozygote embryo. (A-C) cells in G1 stage, Cdt1-mCherry (red); (A’-C’)
cells in S/G2/early M phase, zGem-Cer (blue); (A”-C”) merged image.
Bar = 50 µm.
To determine what kind of indel mutation was caused by the
CRISPR/Cas9 mutagenesis, R. Warga (unpublished) used a PCR amplification
method to extract DNA from 16 clones to sequence. Sequencing showed that the
CRISPR/Cas9 mRNA injection resulted in a splice site mutation with deletion of
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the AG donor splicing site and insertion of 4 nucleotides GGAT (Fig. 25), which
might lead to the translation of an an abnormal Cyclin B1 protein.
We showed that the mutation caused by CRISPR/Cas9 system indeed
failed to complement, therefore the mutation caused in cyclin B1 gene should be
the cause the spr mutant phenotype.

A

B

Figure 25. DNA sequencing chromatogram of cyclin B1 gene of the wild-type
embryo and the transheterozygote.

Sequencing of the cyclin B1 gene reveals a splice-site mutation in
transheterozygotes (B) in exon 2 (Rachel Warga, unpublished. (A) Donor site
AG in the wild-type embryo (black frame). (B) Detelion of an AG donor site and
insertion of GGAT in the mutant (red frame).

Summary

In this chapter I showed that by mutagenizing cyclin B1 gene using
CRISPR/Cas9 system, we caused changes in cell cycle progression similar to
those of the spr mutant phenotype. We successfully showed that embryos
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derived from the germline experiments failed to complement, which supported
our hypothesis that the mutant phenotype is a result of disruption in the cyclin B1
gene. Mutation caused by CRISPR/Cas9 mRNA is a splice site mutation that
presumably disrupted the production of the normal Cyclin B1 protein, required for
the cell cycle progression.
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CHAPTER V
DOUBLE MUTANT PHENOTYPE
Background

The Harpy Mutant Phenotype

harpy (hrp) is a Mendelian recessive mutation; early arrest mutants were
isolated from the Tübingen screen (Kane et al., 1996). The hrp mutant phenotype
is caused by mutation of the coding region of early mitotic inhibitor1 (emi1) also
called RCA1 in Drosophila, resulting in premature stop codons. hrp is
characterized by a very distinct morphological and cellular phenotype:
abnormally “bumpy head”, shortened body axes, no apparent cell death, big
nuclei due to lack of cell divisions that occur after 6 hours of development (Riley
et al., 2010). During S and G2 phases the Anaphase Promoting Complex
(APC/C), which promotes degradation of cyclins, is inhibited by Emi1 in order to
accumulate Cyclin A and B and to prevent re-replication (Moshe et al., 2011). We
would predicted that hrp would be epistatic to spr because Emi1 acts upstream of
Cyclin B1.

The Zombie Mutant Phenotype
The zombie early arrest mutants were isolated from the Tübingen screen.
zombie mutant embryos segregate as simple Mendelian recessives. The
phenotype displays gross cellular abnormalities before morphological changes in
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tissue and body shape are obvious (Kane et al., 1996). This phenotype is visible
as early as the 4-somite stage: embryos tend to be opaque, cells are larger and
rounded (Kane et al., 1996). Mutants with the zombie phenotype were mapped to
linkage group 2 (T. Dams, unpublished) in the vicinity of the cdc20 gene.
Sequencing data showed that zombie mutant embryos have a nonsense
mutation in the cdc20 gene, resulting in a prematurely terminated protein and
nonsense mediated degradation of cdc20 mRNA. As in spr mutant embryos,
zombie mutant embryos have only maternal cdc20 mRNA supplies, which
deplete after the midblastula transition (Kane lab, unpublished). Cdc20 activates
the Anaphase Promoting Complex (APC), which in turn ubiquitinates Securin and
releases Separase to degrade Cohesins that hold sister chromatids together
during the metaphase-anaphase transition. Another important role of the APC/C
is to degrade all the S and M cyclins (Zachariae & Nasmyth, 1999; Harper et al.,
2002).
The cellular zombie mutant phenotype is characterized by arrest of the cell
cycle during the metaphase/anaphase transition, as was shown with DAPI
staining (Kane et al., 1996). This phenotype was confirmed by antibody staining
for a mitosis marker (phosphorylated form of histone H3): metaphase/anaphase
arrest can be seen as early as the 3-somite stage, and the number of cells
arrested in mitosis is higher than in wild-type embryos (Kane lab, unpublished).
In this chapter I would like to concentrate on Cyclin B1, Emi1 and Cdc20
as essential cell cycle players, their interaction and possible outcomes for double
mutant phenotypes. By this analysis, I would reveal how known cell cycle
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proteins influence the progression of the cell cycle in zebrafish embryos during
early development.
Results

Morphological and Cellular Phenotype of the specter/harpy Double Mutant
To examine the effect of hrp/spr double mutation, I crossed fish
heterozygous for hrp with fish heterozygous for a spr mutation. I expected to see
double mutant phenotype in the F2 in the ratio 9:3:3:1. In the F2 I got the
following numbers: 296 wild type, 120 spr, 95 hrp, 41 spr/hrp.
Morphologically I was able to distinguish 4 groups of embryos in the F2
generation. The first group, the biggest, was wild-type embryos; second – the spr
mutant embryos; third – the hrp mutant embryos; and forth – double mutant
embryos with aspects of the hrp and spr mutant phenotype.
The double mutant morphological phenotype had aspects of both parents:
body length was like in the hrp mutant embryos, however, the somites were more
organized and better formed, which resembled the spr mutant phenotype (Fig.
26, A-D). Double mutant embryos had extruded eyes like the hrp mutant
embryos. Double mutants also had opaque head, which is not normal for the hrp
mutant embryos, suggesting that these embryos might undergo apoptosis like
the spr mutant embryos.
To examine the nuclear phenotype I performed DAPI staining of the same
embryos at 20 hours (Fig. 26, A’-D’). Wild-type embryos had normal size and
shape nuclei. spr mutant embryos had abnormal and enlarged nuclei with signs
of apoptosis. hrp mutant embryos had very big nuclei, typical for this mutation.
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Double mutant embryos had a heterogeneous population of nuclei: some nuclei
were as big as in hrp mutant embryos, some had an abnormal shape and as big
as in spr mutant embryos with signs of programmed death. Interestingly only in
double mutant embryos I was able to clearly see cells in early mitosis; these
mitotic stages were not easily observed in either single mutant.

Fig. 26 Characterization of harpy/specter double mutant embryos. (A-D),
morphological phenotype at 20 hours, side view; (A’-D’) nuclear phenotype
(DAPI) at 20 hours; (A”-D”) cellular phenotype (antibody staining for
phosphorylated form of histone H3) at 24 hours side view, of wild-type, spr,
hrp, hrp/spr double mutant embryos, respectively. Bar = 20µm.
Ongoing mitosis in the double mutant embryos suggested that the cell
cycle progression is changed in these embryos. Therefore, I stained embryos for
the phosphorylated form of histone H3 to analyze the cellular phenotype. The hrp
mutant embryos do not have cells dividing; therefore, I assumed that if double
mutant embryos would have cells in mitosis, then it would be an effect caused by
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lack of Cyclin B1, because these cells might be arrested at this stage. The
double mutant embryos had some cells in mitosis, however fewer than in the spr
mutant embryos. Suggesting that spr is epistatic to hrp in terms of pH3 staining.
These data helped me to analyze how the cell cycle might progress when
zygotic Emi1 and Cyclin B1 are absent in mutant embryos. Emi1 is necessary for
Cyclin B accumulation during S phase. In general, the hrp mutant phenotype can
be distinguished earlier than the spr mutant phenotype (Railey et al., 2010).
Therefore, I hypothesize if there is a lack of maternal Emi1 earlier than cyclin B1,
then cells would undergo S phase, activate the APC/C complex and continue
resembling a normal phenotype until maternal Emi1 is depleted. As soon as
maternal supplies of Emi1 are depleted, cells cannot regulate the APC/C
complex, which leads to re-replication, observed in typical hrp mutant embryos.
The cell cycle is not affected in spr mutant embryos as it is in hrp mutant
embryos. This suggests, that there might be enough Cyclin B1 to ensure the
onset of mitosis. APC/C complex ensures degradation of Cyclin B, therefore,
double mutants cannot show a pure spr phenotype: possible supplies of Cyclin B
get degraded earlier by an activated APC/C complex, due to the absence of
Emi1.

Morphological and Cellular Phenotype of the Specter/Zombie Double Mutant

The zombie mutant embryos arrest at the metaphase-anaphase transition,
due to the lack of Cdc20. The spr mutant embryos delay in the cell cycle
progression and cells might get arrested before entering mitosis. In the spr/zom
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double mutant embryos I hypothesize the spr phenotype to be epistatic, because
Cyclin B1 acts earlier in the cell cycle. To check my hypothesis, I performed the
same morphological, nuclear and cellular analysis, as described for the spr/hrp
double mutant embryos (Fig. 27).
I got the following numbers after crossing the double mutant fish: 72 wild
type, 36 spr, 26 zom, and 11 spr/zom. The spr mutant phenotype seemed to be
epistatic by morphological characteristics compared to zom mutant embryos. The
double mutant embryo did not have such a dark head like the zom mutant
embryos did not have such a dark head, had longer body axes, and
distinguishable somites (Fig. 27, A-D). The nuclear phenotype showed a lot of
abnormal nuclei, apoptotic nuclei in double mutant embryos with a small group of
cells in mitosis; this resembles the nuclear phenotype of the spr mutant embryos.
I saw very few cells in mitosis in double mutant embryos; this was confirmed with
phospho-histone H3 staining (Fig. 27, A”-D”).
Double mutant embryos had more cells in mitosis, but at lower rates than
in both zom mutant embryos and in wild-type embryos. Interestingly, enveloping
layer cells (EVL), were positive for the pH3 mitotic marker, which does not occur
as much in the spr mutant embryos.
The zom mutant phenotype acts earlier than the spr mutant phenotype;
nonetheless, in this case, APC/C complex is not being activated, therefore it
cannot interfere with Cyclin B1 that acts earlier. On the other hand, considering
the fact that there are fewer cells arrested in mitosis in the double mutant
embryos, it suggests that the spr mutation and Cyclin B1 depletion happen
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sometime right after depletion of Cdc20, but not at the same time. In this case,
most of the cells will be locked in S/G2/early M phase, with an apoptotic pattern
which is a characteristic of the spr mutant phenotype.

Fig. 27 Characterization of zombie/specter double mutant embryos. (A-D),
morphological phenotype at 15 hours, side view; (A’-D’) nuclear phenotype
(DAPI) at 20 hours; (A”-D”) cellular phenotype (antibody staining for
phosphorylated form of histone H3) at 15 hours side view, of wild-type, spr,
zom, zom/spr double mutant embryos, respectively. Bar = 20µm.

Summary
I showed that the spr mutant phenotype is epistatic to both, hrp and zom
in morphological phenotype. The double mutant phenotype resembles
characteristics of both mutations: for example, in the spr/hrp double mutant
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embryos, cells enter mitosis and show signs of cells death. In the spr/zom double
mutant embryos, there are more cells in mitosis, but they are not arrested at the
metaphase-anaphase transition. Observed phenotypes might be explained by
when the Cyclin B1 or Emi1 or Cdc20 are required and when they are depleted in
different cell lineages. For instance, this might explain EVL cells arrested in
metaphase-anaphase in the spr/zom double mutant embryos. EVL cells finish
their cell cycle with division 11. If the spr/zom double mutant embryos run out of
Cdc20 by that time, than EVL cells cannot exit mitosis.
The spr/hrp double mutant embryos probably get arrested before cells can
enter mitosis, with come cells entering M phase. Due to the lack of Cyclin B1, the
cells cycle in these mutant embryos is also delayed, which might cause nuclear
instability and apoptosis like in the spr mutant embryos. These results indicate
that the mutations in Cyclin B1, Emi1 and Cdc20 are disruptive for the normal
progression of the cell cycle.
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CHAPTER VI
DISCUSSION

Based on identification of the mutant sequence and reproduction of the
mutant phenotype by complementation test with a newly generated CRISPR
mutation, we have shown that the spr mutant is caused by the mutation in the
cyclin B1 gene. Here we discuss changes in the spr mutant phenotype during
early zebrafish development.
Introducing the premature stop-codon in exon 2 of the cyclin B1 gene
resulted in a dysfunctional gene, which led to changes in the morphological
phenotype, similar to the morphological phenotype of the crash-and-burn (crb, or
b-myb) zebrafish mutant embryos: darkening of the head and elevated apoptosis
(Stern et al., 2005). B-myb is a transcricption factor that regulates progression
through the G1 to S phases of the cell cycle. b-myb knockdown in human cells,
Drosophila and zebrafish leads to a reduction of cyclin B1 and cdk1 expression,
thus regulating G2 and M phase of the cell cycle (Okada et al., 2002; Shepard et
al., 2005; Zhu et al., 2004). spr mutant embryos also have high rates of cell
death, however the nature of this cell death remains unclear. In the case of bmyb mutant embryos, their abnormal monopolar spindles originated from a single
or unseparated chromosomes, unorganized and multipolar spindles which cause
catastrophic mitosis, mitotic arrest and cell death (Shepard et al., 2005; Stern et
al., 2005). This genomic instability might not be caused directly by the mutation in
b-myb, since Cyclin B1 is the key player in spindle formation (Nam and Deursen,
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2014). Therefore, reduced Cyclin B1 expression in b-myb embryos might be the
reason for such cellular phenotype.
However, there was no further and detailed histological or cellular
description of the mutant lacking functional Cyclin B1 in the reviewed literature.
We found that the lack of functional Cyclin B1 causes cells to acquire different
cell cycle progression resulting in the majority of the cells appearing to be in
S/G2 phase by 20 hours of development. According to our analysis of the mitotic
cells, we hypothesize that cells seen in mitosis at the 7-somite stage are the cells
that do not exit the cell cycle and might have a delayed and extended cell cycle
progression if not get arrested, and no more cells enter mitosis after this stage.
This would support the general importance of the Cyclin B1 for normal cell cycle
progression (reviewed by Malumbres, 2001). Even low levels of nondegradable
Cyclin B1 are sufficient to arrest cells at the metaphase-anaphase transition;
therefore unless there is no Cyclin B1 in the cells during M phase, no cells can
undergo mitosis (Chang et al., 2003). Enlarged nuclei in some cells of the spr
mutant embryos, however, suggest that the spr mutant embryos undergo rounds
of S phase without mitosis. However, with the obvious changes in morphology of
the spr mutant embryos, there are no visible changes at the cellular level. One
possible explanation for this, is that maternal Cyclin B1 can provide the embryo
with enough levels of Cyclin B1. Once maternal Cyclin B1 is depleted, zygotic
Cyclin B2 could compensate for Cyclin B1 and form a Cyclin B2/Cdk1 complex. It
is possible that Cyclin B2 cannot fully replace Cyclin B1, and cells eventually
undergo G2/M arrest of the cell cycle (Wu et al., 2010).
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We found through in situ hybridization that there are fewer blood cells but
they are bigger. This is a common characteristic observed in the cell cycle
mutant embryos in the Kane lab. Blood precursors born in the gastrula undergo
two more divisions during the segmentation stage in the wild-type embryos
(Warga et al., 2009). Due to disruptions in the spr mutant embryos cell cycle,
such as delay in cell cycle progression, possible arrest at G2/M phase and vast
cell death, the last divisions of blood cell precursors (hemangioblast lineage)
might not occur as fast as in wild type. In addition, endoreplication might explain
why the blood cells are bigger in the mutant embryos.
Within the central nervous system of the spr mutant embryos, we found
that there was fewer and bigger in size spinal interneurons, and sensory and
motor neurons. Rohon-Beard (RB) cells are large sensory neurons that are
specified at the neural plate stage, and are among the earliest specified neurons
in the zebrafish (Korzh et al., 1993). We saw changes in the RB pattern possibly
due to apoptosis, which normally occurs no earlier than at 3-4 days of
development. Primary motor neurons undergo a final S phase between 9 and 16
hours. They have segmental organization that correlates with the pattern of
adjacent axial muscles that they innervate (Eisen, 1992). However, the final cell
cycle might be delayed in mutant embryos, giving rise to less motor neurons, a
deficit that is compounded by the increase in apoptosis. The same pattern is
seen for spinal interneurons. I have shown that the spr mutant embryos have a
high number of apoptotic cells in the brain and along the body axes, as the
embryo develops. These data suggest that cells born later might be affected by
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both: first, cell cycle abnormalities, such as longer cell cycle progression and
possible arrest at G2/M phase; second, by the increasing apoptosis that occurs
predominantly in the nervous system, which explains the opaque head, and
missing cells in the nervous system in the spr mutant embryos.
Histological analysis of muscle precursors showed delayed and weaker
expression of MyoD. The segmentation clock coordinates the unsegmented
presomitic mesoderm (PSM), the rhythm of somite formation (Venters et al.,
2008). The Notch signaling pathway has long been known to be the first major
player to regulate this signal (Kopan and Ilagan, 2009; Shin et al., 2007). Also,
the hairy/E gene family of bHLH transcription regulators, such as her1 and her7
in zebrafish, and the Notch ligand Delta (Oates and Ho, 2002; Pasini et al., 2004)
regulate somites formation. It was previously shown, that Notch signaling
coordinates individual cells and synchronizes them (Zhou et al., 2010). We found
that the somite borders in the spr mutant embryos are not disorganized. When
Notch signaling fails, individual cells lose their synchrony, and changes in somite
patterning occur (Lewis, 2003; Lewis et al., 2009). We showed that notch1b
expression is delayed and weaker in the spr mutant embryos, which might
explain delayed expression of MyoD. We did not identify whether there are any
changes in her1 and her7 expression in the spr mutant embryos; however loss of
the expression of these genes disrupts segmentation along the body axis
(Kawamara et al. 2005; Oates and Ho, 2002).
Emi1 mutant embryos zebrafish also have abnormalities in somite
morphology: they are hyper-epithelialized, have no internal mesenchyme and
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have elongated epithelial border cells that fuse and create segments of different
sizes (Zhang et al., 2008). In the absence of the normal cell cycle in the emi1
mutant embryos, the internal mesenchymal cells exit the core of the somite after
initial boundary formation. Zhang et al. (2008) showed that disruption of the cell
cycle in the emi1 mutant embryos does not interfere with the segmentation
period for the segmentation clock function, but is necessary for the normal
segmentation arrangement of epithelial borders and internal mesenchymal cells
(Zhang et al., 2008). Non-functional Cyclin B1 seems to be important for the
segmentation clock function as well as segmentation morphology, perhaps due
to disruptions in the Notch signaling pathway.
Histological analysis of notch1b and deltaa expression showed that
expression is delayed and weaker for markers of the Notch signaling pathway,
and much weaker for Delta. Predominantly, our results reveal that some
population of notch cells do not enter the Delta pathway. Therefore, we observe
fewer neurons forming. Some Notch positive cells seem to enter the Delta
pathway and give rise to neurons.
Through the lack of complementation, we confirmed that the spr mutant
phenotype is a result of a disruption in the cyclin B1 gene. Mutagenized clones
created by the CRISPR/Cas9 system injection contain a splice site mutation that
disrupts normal splicing of the cyclin B1 gene. It is possible that the translated
product in these clones is not sufficient for the normal function and maintenance
of the MPF complex. Morphological and cellular analysis of the
transheterozygotes revealed characteristics of typical spr mutant embryos. This

69

suggests that the introduced mutation indeed gave rise to a non-functional Cyclin
B1 product.
In summary, we have shown that the spr mutation is a result of a mutation
in the cyclin B1 gene that disrupts normal progression of the cell through the cells
cycle causing morphological and cellular changes. By analyzing cell cycle mutant
embryos we can reveal how cell cycle progression determines early development
in not only zebrafish embryos, but in other organisms, since the cell cycle
mechanism is conserved in many live systems.
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CHAPTER VII
METHODS
Zebrafish Strains

The spr tu21 allele was isolated in a large-scale mutagenesis screen
(Haffter et al., 1996). Embryos produced by natural spawning of heterozygotes
were initially kept in E3 medium (5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl2 2H20,
0.33 mM MgSO4 7H2O) (Mullins et al., 1994). Manually dechorinated embryos
were kept in Danieau’s media (58 mM NaCl, 0.7 mM KCl, 0.4 mM MgSO4 7H2O,
0.6 mM Ca(NO3)2, 5 mM HEPES) (Driever et al., 1998), incubated at 25°C to
33°C. For histological analysis embryos were fixed in 4% paraformaldehyde in
1X PBS (137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4 7H2O, 1.4 mM KH2PO4).
To produce heterozygous fish for spr carrying the Dual FUCCI reporter
(Bouldin et al., 2014), fish heterozygous for spr were outcrossed to the Dual
FUCCI line, selecting individuals for the fluorescent reporter at 3 days of
development. After fish were grown up, they were incrossed, selecting individuals
heterozygous for spr and carrying Dual FUCCI reporter as viewed under a
dissection microscope using the Texas Red filter.
spr/hrp and spr/zom double mutant embryos were produced by mating fish
heterozygous for zom or hrp to fish heterozygous for the spr mutant allele.
Embryos from this cross were grown and ¼ from each cross was identified as
double heterozygous. Analysis of double mutant embryos was performed on G2.
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Whole Mount In Situ Hybridization and Antibody Staining

Antibody staining was performed as described in Riley et al. (1999) and
Phillips et al. (2006) using commercial antibodies against rabbit phospho-histone
H3 (1:200) and rabbit phospho-caspase-3 (1:200). RNA in situ hybridization was
carried out as described (Thisse et al., 1993) using riboprobes against hhbe,
lplast, mpx, pax2a, islet 1, notch1b, deltaa, MyoD and krox20. For the in situ
probe used the purple Nitro-Blue tetrazolium Chloride/Bromo Chloro
Indolphosphate p-Toluidine chromogen product. Cleared in 70% glycerol and
photographed with Sony F-707 Digital Camera.

DAPI Staining

Embryos were fixed and stained simultaneously in a solution of 4% PFA,
Dimethyl sulfoxide and 0.01% DAPI. Embryos were dissociated by gently
crushing between coverslips before photographing. Analyzed under using Zeiss
Axiophot II equipped with a CDC-300-RC camera (DAGE MTI).

mRNA Injection

Embryos manually dechorinated in Petri dishes with 2% Bacto agar in
100% Danieau’s media (Driever et al., 1998) (58 mM NaCl, 0.7 mM KCl, 0.4 mM
MgSO4 7H2O, 0.6 mM Ca(NO3)2, 5 mM HEPES) were injected at 1-8 cell stage
with wild-type tailed cyclin B1 mRNA (Rachel Warga, unpublished). Control
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embryos were injected with equivalent amounts of kaede mRNA. After the
injection, Penicillin Streptomycin (1:100) was added into Danieau’s media;
embryos were incubated at 33°C.

CRISPR/Cas9 Mutagenesis

Creating Cas9 mRNA and sgRNA
Cas9 mRNA and single guide mRNA were created as described in Hwang
et al. (2013). Briefly, Cas9 nuclease expression plasmid DNA encoding the Cas9
nuclease was amplified from the pMJ806 vector (Addgene Plasmid #39312) by
PCR using the following primers:
OMM704: 5’ ataagaatgcggccgctaatacgactcactatagggagagccgccaccATGGATAAG
AAATACTCAATAGGCTTAG 3’
OMM705: 5’ gtacataccggtcatcctgcagctccaccgctcgagactttcctcttcttcttgggagaaccGT
CACCTCCTAGCTGAC 3’.
The PCR product was digested with the NotI and AgeI restriction enzymes and
inserted into plasmid pMLM651.
Single guide RNA (sgRNA) expression vector Vector pDR274RC
harboring a T7 promoter positioned upstream of a partial guide RNA sequence
was generated by commercial DNA synthesis (Integrated DNA Technologies). To
create plasmids encoding sgRNAs bearing 20 nt targeting sequences, we
digested with BsaI restriction enzyme, then cloned a pair of designed and
annealed oligonucleotides into the vector backbone. The annealed
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oligonucleotides have overhangs that are compatible with directional cloning into
the BsaI-digested pDR274 vector.
To identify potential target sited for our sgRNA:Cas9 system, we used
web-based ZiFit Targeter Sofware.
To produce sgRNA and Cas9 mRNA, sgRNAs were transcribed using the
DraI-digested gRNA expression vectors as templates and the MAXIscript T7 kit
(Life Technologies). The Cas9 mRNA was transcribed using PmeI-digested Cas9
expression vector and the mMESSAGE mMACHINE T7 ULTRA kit (Life
Technologies). Following completion of transcription, the poly(A) tailing reaction
and DNase I treatment were performed according to the manufacturer’s
instructions for the Cas9-encoding mRNA. For sgRNA: to purify the plasmid we
used QIAGEN plasmid midi kit, restriction digest using DRA-I, to purify DRA-I
DNA we used QUAquick PCR purification Kit protocol. sgRNA was transcribed
using MAXIscript T7 kit (Life Technologies).

Zebrafish Mutagenesis
Embryos derived from a wild-type parent and a heterozygote for spr were
co-injected at 1-2 cell-stage with sgRNA and Cas9 mRNA. Further analysis was
done using antibody staining against phospho-cas-3.
Embryos derived from zebrafish with wild-type background were coinjected at 1-2 cell-stage with sgRNA and Cas9 mRNA. These embryos were
grown up and crossed heterozygotes for spr carrying Dual FUCCI transgene.
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PCR Amplification

Target locus was amplified by PCR from pooled genomic DNA of 16
mutant and wild-type embryos derived from the CRISPR/Cas9 mutagenized fish
crossed to fish heterozygous for spr mutant allele. Primers used:
F: 5’ acctaactgtttaagccac 3’
R: 5’ ccaccgtcatacagtaataac 3’
Reamplified PCR product was sent to University of Michigan Sequencing Core.

Time-Lapse and Data Analysis

For in vivo observations of embryos carrying Dual FUCCI transgene,
embryos were mounted and recorded in multi-plane as previously described
(Warga and Kane, 2003) using Nikon C2 confocal microscope. Embryos were
mounted during gastrulation in 0.2% agarose between coverslips and sealed with
Vaseline. Recorded using 60x water and oil emersion lens at 10 to 15 planes
using 5 to 10 µm z-spacing for periods of 2 to 6 hours. In a single experiment,
groups of 6 to 8 individuals were recorded using a computer controlled stage,
each location was recorded every 5 to 10 minutes. Temperature in the room was
maintained around 30°C. By the end of recording, embryos were carefully
removed from between the coverslips, placed intro Danieu’s media with Penicillin
Streptomycin (1:100), incubated at 33°C, and their phenotypes were determined
the next day. Older embryos with distinct phenotypes were sorted by the
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phenotype before mounting. Afterward, the recordings were analyzed using NIS
Elements Viewer 4.20 Software and Adobe Photoshop.

Statistical Analysis

To determine statistical significance of number of apoptotic cells and cells
in mitosis standart deviation and standart errors were used.
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